No registrations found.
ID
NL-OMON26541
Source
Nationaal Trial Register
Health condition
CML, chronic myeloid leukemia, chronische myeloïde leukemie.
Sponsors and support
Primary sponsor
:
Radboudumc Nijmegen
Source(s) of monetary or material Support
:
Radboudumc Nijmegen
Intervention
Outcome measures
Primary outcome
Muscle complaints
Fatigue
Secondary outcome
Physical activity, BMI, daily fluid intake
Background summary
The aim of the present study is to identify risk factors for muscle symptoms and fatigue in patients with chronic myeloid leukemia on tyrosine kinase inhibitor treatment using an online questionnaire. Furthermore, quality of life will be assessed.
Study design
Cross-sectional
Intervention
None
Public
Scientific
Inclusion criteria
Diagnosed with CML
Aged >=18 years
Exclusion criteria
Aged <18 years
Design
Study type
:
Observational non invasive
Intervention model
:
Other
Masking
:
Open (masking not used)
Control
:
N/A , unknown
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
140
Type
:
Anticipated
Positive opinion
Date
:
Application type
:
First submission
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL7102 |
| NTR-old | NTR7308 |
| Other | CMO : 2018-4233 |